Advertising, Sponsorship & Supplements

17.1 Purpose and Principles

  • This policy keeps editorial decisions independent from commercial influence. Advertising, sponsorship, and supplements are allowed only when they are clearly labeled, accurate, and separate from peer-reviewed content. Revenue arrangements never affect acceptance decisions, peer review, or research conclusions.

17.2 Firewalls and Governance

  • Editorial firewall: Editors, reviewers, and editorial board members have no role in advertising sales, sponsorship negotiations, or billing.
  • Commercial firewall: Sales and marketing teams have no access to confidential editorial content or peer-review files.
  • Conflict checks: Any staff member involved in both editorial and commercial activities must declare and manage conflicts; dual roles in the same workflow are prohibited.

17.3 Clear Labeling and Distinction

  • Display ads are labeled “Advertisement.”
  • Sponsored content (publisher-created or partner-provided) is labeled “Sponsored” or “Paid Content,” includes the sponsor’s name, and is not peer reviewed unless explicitly stated.
  • Supplements (sponsored issues/collections) are labeled on the cover, table of contents, and each article landing page with sponsor disclosures and the handling editor’s identity.
  • Native ads and advertorials are permitted only with unambiguous labeling and a style that prevents confusion with editorial design.

17.4 Placement and Ad Serving

  • Ads never appear within peer-review reports, editorial decisions, or PDF article bodies.
  • Ads do not interrupt reading flows of article HTML (e.g., no interstitials that block access to the Version of Record).
  • We prohibit ad placements adjacent to content where it would create misleading associations (e.g., disease claims next to clinical trial outcomes) unless a clear disclaimer is present.

17.5 Acceptable vs. Prohibited Advertising

  • Acceptable: products and services relevant to research, education, healthcare, or professional practice, provided claims are truthful, evidence-based, and lawful in target jurisdictions.
  • Prohibited: Illegal products/services; discriminatory or hateful content; political campaign ads; misleading “miracle cures”; spyware or deceptive software; adult sexual content; tobacco; weapons and explosives; predatory publishing services; deepfake or synthetic identity products; any ad that conflicts with our research-integrity standards.

17.6 Claims, Evidence, and Safety

  • Health or performance claims must be substantiated by competent evidence; references may be requested.
  • Comparative claims require fair comparisons with current, representative products.
  • Ads must comply with local law (e.g., device/pharmaceutical rules, financial promotions). We may geo-restrict or decline ads that do not meet standards.

17.7 Targeting, Privacy, and Data Use

  • Targeting uses minimal, privacy-respecting data; we do not sell personal data to advertisers.
  • Behavioral targeting (if used) follows our Privacy & Cookies policy, honors consent choices, and excludes sensitive attributes (health status, race, religion, sexual orientation).
  • Advertisers do not receive access to user-level browsing of peer-review content; reporting is aggregated and de-identified.

17.8 Third-Party Ad Tech and Measurement

  • Ad servers and measurement providers must adhere to data-processing agreements and security standards.
  • We vet tags/SDKs for privacy, performance, and accessibility impacts; intrusive or unsecure scripts are rejected.
  • Metrics (impressions, clicks) are reported consistently and may be audited.

17.9 Editorial Independence in Sponsored Content

  • Sponsors have no editorial control over peer-reviewed articles or acceptance decisions.
  • For sponsored features (non-peer-reviewed): we retain final edit rights to ensure accuracy, tone, and compliance; sponsor review is limited to factual checking of sponsor-provided details.
  • Any financial relationship relevant to content is disclosed prominently.

17.10 Supplements (Sponsored Issues/Collections)

  • Peer review: Articles in supplements undergo the same peer-review and ethics standards as regular content; deviations (if any) are stated on the supplement page.
  • Oversight: A senior editor (independent from the sponsor) oversees reviewer selection and decisions; sponsors cannot select reviewers or influence outcomes.
  • Disclosures: Each article lists the sponsor, funding source, and sponsor role; data access and analysis independence are stated.
  • Indexing: Supplements are indexed as part of the scholarly record with their own DOIs; corrections and retractions follow standard policy.

17.11 Industry-Funded Research and Medical Marketing

  • Advertisements from pharma/biotech/medical device firms must comply with applicable advertising laws and avoid misleading therapeutic claims.
  • Promotion of off-label uses is prohibited.
  • Sponsored educational content must disclose all funding and potential conflicts; faculty/speakers provide COI statements.

17.12 Gifts, Inducements, and Undue Influence

  • We do not accept gifts, travel, or hospitality that could reasonably be seen as influencing editorial or advertising decisions.
  • Discounts, bundled packages, or partner deals must not create preferential editorial treatment.

17.13 Complaints and Corrections (Commercial Content)

  • Readers may report misleading or inappropriate ads via a public contact channel.
  • We investigate promptly; remedies may include ad removal, labels correction, or public notes.
  • For sponsored content and supplements, factual errors are corrected with transparent notices; severe breaches may lead to withdrawal of the item and notice to relevant authorities.

17.14 Archiving and Transparency

  • Sponsored materials and supplements are preserved and labeled permanently.
  • A public Commercial Content Register lists current and recent sponsors of supplements and major campaigns, with dates and scopes.

17.15 Accessibility and Technical Standards

  • Ads and sponsored content must meet WCAG 2.2 AA where feasible; no flashing content >3 Hz; keyboard operable; alt text for informative images.
  • Heavy or intrusive creatives (auto-play audio, large CPU usage) are blocked.

17.16 Changes to This Policy

  • Substantive changes are versioned with a last-updated date and communicated to advertisers and readers where appropriate.